S&P 500 7,663.43 −1.21%
Nasdaq 26,008.86 −2.60%
S&P/TSX 35,973.45 −0.97%
Apple 348.22 +1.23%
Nvidia 212.21 −4.40%
Microsoft 521.08 −2.23%
Shopify 236.41 −3.48%
Royal Bank 282.78 −0.30%
CAD/USD 0.7136 +0.20%
PRE-MKT · 04:25 ET
Market ClerkRecap
Fri Oct 23 · pre-market6 signals on Oct 22103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

ATAI

AtaiBeckley Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
No price history available

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose ATAI in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Apeiron Investment Group Ltd. and 4 related0.0%
SCHEDULE 13D/A · filed Sep 14 · activist · EDGAR ↗

“Item 4 of the Schedule 13D is hereby amended and supplemented in its entirety as follows: As previously disclosed, on July 15, 2026, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Eli Lilly and Company, an Indiana corporation ("Parent"), and Albali Acquisition…”

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch ATAI. Know when insiders buy.
One email the day a filing lands. Free.